RITSUKO KOMAKI to Vascular Endothelial Growth Factor Receptor-2
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Vascular Endothelial Growth Factor Receptor-2.
Connection Strength
0.130
-
Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007 Dec 01; 69(5):1534-43.
Score: 0.066
-
Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade. Mol Cancer Ther. 2007 Feb; 6(2):471-83.
Score: 0.063